Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Am J Transplant. 2013 Dec 4;14(1):49–58. doi: 10.1111/ajt.12525

Figure 7. Cytotoxicity of recipient CD8 T cells against MHC class I-deficient allogeneic BM.

Figure 7

B10.S mice were conditioned with 3 Gy TBI and anti-CD4 mAb on Day −1, anti-NK1.1 mAb on Days −7 and −2, and anti-CD154 mAb on Day 0 with or without (control) 20×106 KbDb−/− TCD BM cells on Day 0. On Day 8–9 post-transplant, 2–3 recipients in each group were euthanized and their splenocytes were pooled. Splenic CD8 T cells were then isolated by anti-CD8 microbeads. These CD8 T cells were cocultured with Cr51-labeled KbDb−/− and syngeneic B10.S ConA-blasts for 4 hours. Levels of Cr51 in the supernatant were then determined and percent specific lysis was calculated as described (20). Data from two experiments performed with similar results are shown.